UBS Maintains Community Health System at Neutral, Cuts Price Target to $2.55
UBS maintained its Neutral rating and lowered its price target to $2.55 from $3, a 15.0% decrease. The target implies 6.2% upside from the Oct. 30 close of $2.40.
UBS maintained its Neutral rating and lowered its price target to $2.55 from $3, a 15.0% decrease. The target implies 6.2% upside from the Oct. 30 close of $2.40.